AI-enhanced formulation development within Translational Pharmaceutics®

Formulate the right drug product, faster and with a higher probability of success.

Quotient Sciences' AI-enhanced solution combines our formulation and clinical expertise with predictive modeling to accelerate drug product development. 

We apply a powerful artificial intelligence (AI) algorithm to explore formulation alternatives, achieving greater speed and higher success rates to advance molecules through early phases of clinical testing. 

Each project starts with a fresh instance of the algorithm that is unique for each client and hosted in a secure, self-contained environment. All predictions are evaluated by human experts, used to guide formulation decisions into clinical testing, and backed by real data. All formulation and clinical data is stored on Quotient Sciences’ secure servers, protecting confidentiality and IP.

• Faster Formulation Development 

Compresses timelines further, with formulation development completed in up to 50% less time compared to conventional approaches.

• Expanded Formulation Options

Enables exploration of a much broader design space, surfacing more formulation options and evaluating them in parallel in early stage, adaptive clinical trials.

• Reduced API Demands

Completes formulation development with fewer laboratory experiments, lowering API consumption by up to 50%.  

• Predict and Prove

Our experts guide and re-direct the algorithm based on extensive experience in drug formulation and development.